Maxzide-25 (Triamterene and hydrochlorothiazide) tablets, USP, 37.5 mg/ 25 mg, 100-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 0378-0464-01
Class I - DangerousWhat Should You Do?
- Check if you have this product: Lot #: 3087136, Exp 5/20
- Do not eat it: Even if it looks and smells fine, do not consume this product.
- Throw it away or return it: You can return the product to the store for a full refund.
- Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
- Report problems: Report any issues to the FDA's Safety Reporting Portal.
⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.
Recall Details
- Company:
- Mylan Pharmaceuticals Inc.
- Reason for Recall:
- Superpotent Drug: Composite assay results obtained during routine stability testing were slightly above specification.
- Classification:
- Class I - Dangerous
Dangerous or defective products that predictably could cause serious health problems or death.
- Status:
- terminated
Product Information
Full Description:
Maxzide-25 (Triamterene and hydrochlorothiazide) tablets, USP, 37.5 mg/ 25 mg, 100-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 0378-0464-01
Product Codes/Lot Numbers:
Lot #: 3087136, Exp 5/20
Official Source
Always verify recall information with the official FDA source:
View on FDA.govFDA Recall Number: D-0877-2018
Related Recalls
Prasugrel Tablets, USP, 5 mg, 30-count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-5185-93
MYLAN PHARMACEUTICALS
Class I - Dangerous
Failed Dissolution Specifications - low dissolution results
Class I - Dangerous
Labeling: Missing label: Label missing from some prefilled pens.
Class I - Dangerous
Labeling: Missing label on the vial